George Mason University

Scientists captured images showing the development of turbulence as a Coronal Mass Ejection (CME) interacted with the ambient solar wind in the circumsolar space. The Wide-field Imager for Parker Solar Probe (WISPR) Science Team, led by the U.S. Naval Research Laboratory (NRL), captured the development of turbulence as a Coronal Mass Ejection (CME) interacted with the ambient solar wind in the circumsolar space. This discovery is reported in the Astrophysical Journal. Taking advantage of its unique location inside the Sun's atmosphere, the NRL-built WISPR telescope on NASA's Parker Solar Probe (PSP) mission, operated by the Johns Hopkins University Applied Physics Laboratory (JHUAPL), captured in unparalleled detail the interaction between a CME and the background ambient solar wind. To the surprise of the WISPR team, images from one of the telescopes showed what seemed like turbulent eddies, so-called Kelvin-Helmholtz instabilities (KHI). Such structures have been imaged in the terrestrial atmosphere as trains of crescent wave-like clouds and are the results of strong wind shear between the upper and lower levels of the cloud. This phenomenon, while rarely imaged, is thought to occur regularly at the interface of fluid flows when the right conditions arise. "We never anticipated that KHI structures could develop to large enough scales to be imaged in visible light CME images in the heliosphere when we designed the instrument," said Angelos Vourlidas, Ph.D., JHUAPL and WISPR Project Scientist. "These fine detail observations show the power of the WISPR high sensitivity detector combined with the close-up vantage point afforded by Parker Solar Probe's unique sun-encounter orbit," said Mark Linton, Ph.D., head, NRL Heliophysics Theory and Modeling Section and Principal Investigator for the WISPR instrument. The KHI structures were detected by the keen eye of an early career member of the WISPR team, Evangelos Paouris, Ph.D., George Mason University. Paouris, and his WISPR colleagues, undertook a thorough investigation to verify that the structures were indeed KHI waves. The results not only report an extremely rare phenomenon, even at Earth, but also open a new window of investigation with important consequences for the civilian and Department of Defense (DOD) communities. "The turbulence that gives rise to KHI plays a fundamental role in regulating the dynamics of CMEs flowing through the ambient solar wind. Hence, understanding turbulence is key in achieving a deeper understanding of CME evolution and kinematics," said Paouris. By extension, this knowledge will lead to more accurate forecasting of the arrival of CMEs in Earth's vicinity and their effects on civilian and DOD space assets, thus safeguarding society and the warfighter. "The direct imaging of extraordinary ephemeral phenomena like KHI with WISPR/PSP is a discovery that opens a new window to better understand CME propagation and their interaction with the ambient solar wind," Paouris said. WISPR is the only imaging instrument aboard the NASA Parker Solar Probe mission. The instrument, designed, developed and led by NRL, records visible-light images of the solar corona and solar outflow in two overlapping cameras that together observe more than 100-degrees angular width from the Sun. This NASA mission travels closer to the Sun than any other mission. PSP uses a series of Venus flyby's to gradually reduce its perihelion from 36 solar radii in 2018 to 9.5 in 2025. The mission is approaching its 19th perihelion on March 30, 2024 at a distance of 11.5 solar radii from Sun center. By observing the data the team found the Kelvin-Helmholtz instability is excited at the boundary between the CME and the ambient wind, as the two are flowing at distinctly different velocities. The resulting vortex-like structures are analyzed with respect to what the Kelvin-Helmholtz instability predicts, and inferences are presented about what the local magnetic field strength and density must be to allow such an instability in this environment.

NEW YORK, March 14, 2024 /PRNewswire/ -- Redwood Scientific Technologies Inc. (OTC: RSCI) is excited to announce significant milestones achieved in the year ending 2023 and its strategic plans moving forward. The company has conveyed to the Board its confidence in its role as a developer of innovative pharmaceutical products, positioning itself for sustained success over the next 36 months. Jason Cardiff, CEO of Redwood, has initiated discussions with the executive team to establish an oral thin film manufacturing hub in the United States. This initiative aims to make the company self-reliant by minimizing dependency on foreign-sourced pharmaceutical goods. In anticipation of its uplisting, Redwood is preparing to transition to the OTCQB platform, projected for April 2024. 2023 Company Highlights: Completion and audit of the 2023 financials and management reports. Submission of an application for NASDAQ listing, ensuring compliance with market requirements for free trading shares. Successful navigation of the patent application process for Oral Thin Film Manufacturing and the active ingredient in its groundbreaking Smoking Cessation products without challenge. Launch readiness of the fully developed product lineup, including TBX-FREE and TBX-VAPE-FREE. Approval from the Brany Institute on Redwood's IRB for clinical study protocol. Partnership with Jeeva Pharmaceutical for efficacy clinical testing at George Mason University. About Redwood Scientific Technologies Inc.: Redwood Scientific Technologies Inc., based in New York, is a leader in pharmaceutical innovation. Focused on research and development, Redwood strives to revolutionize the healthcare industry with sophisticated drug delivery systems and pioneering pharmaceutical products. The company's dedication to excellence, precision, and enhancing patient well-being underscores its commitment to finding unique solutions for better therapeutic outcomes. For more information, please visit . CEO Statement: "At Redwood Scientific Technologies, we are committed to developing safe and effective products to help the millions of adults and youths reclaim their lives from the clutches of nicotine addiction. Collaborating with this prestigious group will facilitate our mission," stated Jason Cardiff, CEO of Redwood. "Given the current crisis, particularly among the youth, and the alarming levels of nicotine in vape devices, our priority is to quickly bring our products to market for those in dire need." Nicotine, found in cigarettes, vapes, and e-cigarettes, is profoundly addictive, serving as a stimulant and a sedative with detrimental effects on all bodily systems. It is reported that 8 million adults in the U.S. regularly use e-cigarettes, with an additional 28.3 million regularly using traditional cigarettes. Among these, 2.5 million middle and high school students are e-cigarette users, with 16.5 percent of high school students reporting current tobacco use. The CDC highlights that 60 percent of youth tobacco users have attempted to quit, alongside 54 percent of e-cigarette users also trying to cease use. For further information, please contact: Email: [email protected] SOURCE REDWOOD SCIENTIFIC TECHNOLOGIES

ASHBURN, Va., Feb. 8, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Furhan Qureshi is acknowledged as a Pinnacle Lifetime Member for his contributions to the field of Pathology. Dr. Qureshi pursued higher education at George Mason University where he earned a Bachelor of Science degree. He then attended Ross University School of Medicine, graduating with a Doctor of Medicine degree in 2012. He completed an intensive internship at the Icahn School of Medicine at Mount Sinai Program in 2013 and finished a residency at the Leonard J. Chabert Medical Center with a focus on internal medicine in 2015. A specialist in the field of internal medicine, Dr. Qureshi focuses his practice on the pathology of disease, diagnosis, and treatment. He is board-certified in internal medicine and considers his phenomenal success due to several factors, including his dedication to following his philosophy which centers around getting to know his patients and determining the best treatment for them, emphasizing a patient-centered approach and the support and guidance received from his mentors, Dr. Arcement and Dr. Espinoza. The doctor would like to dedicate this honor and express his gratitude to his wife, Deborah; son, Nooryahya; and his parents, Sabrina and Pervez for their love and support. Aside from his professional pursuits, the doctor enjoys travel and spending time with his family. Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com SOURCE The Inner Circle